ARMT
CRL icon

Amica Retiree Medical Trust’s Charles River Laboratories CRL Stock Holding History

Amica Retiree Medical Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$314K Hold
2,007
– – 0.43% 65
2025
Q2 		$305K Hold
2,007
– – 0.44% 65
2025
Q1 		$302K Sell
2,007
-442
-18% -$74.1K 0.46% 65
2024
Q4 		$452K Sell
2,449
-150
-6% -$28.9K 0.43% 60
2024
Q3 		$512K Buy
+2,599
New +$540K 0.42% 62
2023
Q3 		$387K Hold
1,977
– – 0.45% 71
2023
Q2 		$416K Sell
1,977
-126
-6% -$25.1K 0.46% 71
2023
Q1 		$424K Sell
2,103
-2,353
-53% -$533K 0.45% 77
2022
Q4 		$971K Buy
4,456
+182
+4% +$39.7K 1.25% 28
2022
Q3 		$841K Buy
4,274
+924
+28% +$199K 1.05% 29
2022
Q2 		$717K Buy
3,350
+250
+8% +$61.1K 0.81% 46
2022
Q1 		$880K Buy
3,100
+1,357
+78% +$418K 0.82% 36
2021
Q4 		$657K Buy
1,743
+291
+20% +$113K 0.56% 62
2021
Q3 		$599K Sell
1,452
-640
-31% -$266K 0.54% 69
2021
Q2 		$774K Sell
2,092
-1,084
-34% -$362K 0.49% 68
2021
Q1 		$921K Hold
3,176
– – 0.62% 48
2020
Q4 		$794K Hold
3,176
– – 0.56% 53
2020
Q3 		$719K Sell
3,176
-1,230
-28% -$255K 0.56% 53
2020
Q2 		$768K Hold
4,406
– – 0.61% 43
2020
Q1 		$556K Buy
4,406
+752
+21% +$113K 0.5% 52
2019
Q4 		$558K Hold
3,654
– – 0.43% 58
2019
Q3 		$484K Hold
3,654
– – 0.39% 71
2019
Q2 		$519K Buy
3,654
+2,020
+124% +$274K 0.42% 67
2019
Q1 		$237K Hold
1,634
– – 0.21% 145
2018
Q4 		$185K Hold
1,634
– – 0.18% 164
2018
Q3 		$220K Hold
1,634
– – 0.18% 152
2018
Q2 		$183K Hold
1,634
– – 0.16% 171
2018
Q1 		$174K Hold
1,634
– – 0.15% 181
2017
Q4 		$179K Hold
1,634
– – 0.14% 192
2017
Q3 		$177K Hold
1,634
– – 0.14% 194
2017
Q2 		$165K Hold
1,634
– – 0.13% 191
2017
Q1 		$147K Hold
1,634
– – 0.12% 208
2016
Q4 		$124K Buy
+1,634
New +$124K 0.1% 237

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Amica Retiree Medical Trust's CRL Position: Q3 2025 in Review

Amica Retiree Medical Trust held its Charles River Laboratories (CRL) position steady in Q3 2025 at 2,007 shares worth $314K. The position accounts for 0.43% of the portfolio, ranked #65.

Amica Retiree Medical Trust first reported a position in CRL in Q4 2016 and has held it in 33 quarters since. The position peaked at $971K in Q4 2022. 555 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Amica Retiree Medical Trust held 2,007 shares of Charles River Laboratories worth $314K as of Q3 2025.
  • Amica Retiree Medical Trust left its Charles River Laboratories share count unchanged in Q3 2025.
  • Charles River Laboratories made up 0.43% of Amica Retiree Medical Trust's portfolio in Q3 2025, its #65 holding.
  • Amica Retiree Medical Trust first reported a position in Charles River Laboratories in Q4 2016 and has held it in 33 quarters since.
  • Amica Retiree Medical Trust's Charles River Laboratories position peaked at $971K in Q4 2022.
  • 555 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Amica Retiree Medical Trust's 13F filing for Q3 2025, filed 7 Nov 2025.